A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Industry Licensing Information Bookmark and Share

Partner with City of Hope

City of Hope’s primary interest is caring for and healing our patients.  To accomplish this goal, our researchers and clinicians are continuing to push the science of medicine forward. The Office of Technology Licensing assists in this process by facilitating partnerships with companies whose resources and commercial expertise help translate these basic discoveries into commercial products so they may one day be available to the public and improve the health and prosperity of our patients.

Below is a brief overview of some facts and statistics about City of Hope:
 
  • National Cancer Institute-designated comprehensive cancer center; ranked as a best cancer hospital by U.S.News & World Report
     
  • Translationally focused research institute with core areas of research in oncology, HIV/AIDS and diabetes
     
  • 38 active and 9 pending City of Hope investigational new drugs with the Food and Drug Administration
     
  • 300 ongoing clinical trials
     
  • 100 principal investigators
     
  • $323 million in research grants and royalties

Please contact the OTL team to inquire further about any available technologies or to simply learn more about City of Hope.
 

Featured Technology

 
Researchers have designed a mobile phone app that enables patients to improve their self management of diabetes via food and lifestyle choices. Learn more.
 
 
Previously Featured Technology
 
 
Licensing Opportunities
 
City of Hope has developed a range of new technologies many of which are available for licensing to established or startup companies.  Almost all of City of Hope's new technologies fall within the fields of Biotechnology, Pharmaceuticals, Diagnostics or Medical Devices.
 
Please browse the available technologies below:
 
 

Industry Licensing Information

Partner with City of Hope

City of Hope’s primary interest is caring for and healing our patients.  To accomplish this goal, our researchers and clinicians are continuing to push the science of medicine forward. The Office of Technology Licensing assists in this process by facilitating partnerships with companies whose resources and commercial expertise help translate these basic discoveries into commercial products so they may one day be available to the public and improve the health and prosperity of our patients.

Below is a brief overview of some facts and statistics about City of Hope:
 
  • National Cancer Institute-designated comprehensive cancer center; ranked as a best cancer hospital by U.S.News & World Report
     
  • Translationally focused research institute with core areas of research in oncology, HIV/AIDS and diabetes
     
  • 38 active and 9 pending City of Hope investigational new drugs with the Food and Drug Administration
     
  • 300 ongoing clinical trials
     
  • 100 principal investigators
     
  • $323 million in research grants and royalties

Please contact the OTL team to inquire further about any available technologies or to simply learn more about City of Hope.
 

Featured Technology

Featured Technology

 
Researchers have designed a mobile phone app that enables patients to improve their self management of diabetes via food and lifestyle choices. Learn more.
 
 
Previously Featured Technology
 
 
Licensing Opportunities
 
City of Hope has developed a range of new technologies many of which are available for licensing to established or startup companies.  Almost all of City of Hope's new technologies fall within the fields of Biotechnology, Pharmaceuticals, Diagnostics or Medical Devices.
 
Please browse the available technologies below:
 
 

Antibodies

Anti-Virals and Vaccines

Cell Base Therapies

Diagnostics

Disease Models

Gene Therapies

Medical Devices

Peptides and Aptamers

siRNA

Small Molecules

Overview
Office of Technology Licensing
City of Hope
1500 E. Duarte Rd.
Modular 101
Duarte, CA 91010
 
 
 
Center for Applied Technology Development (CATD)
The Sylvia R. and Isador A. Deutch Center for Applied Technology Development (CATD) offers broad expertise in technology transfer and licensing, biologics manufacturing, quality assurance and regulatory affairs.

City of Hope Campus Map
 
 
 
 
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.


NEWS & UPDATES
  • Are you thinking about switching from traditional cigarettes to e-cigarettes for the Great American Smokeout? Are you thinking that might be a better option than the traditional quit-smoking route? Think again. For lung expert Brian Tiep, M.D., the dislike and distrust he feels for e-cigs comes down to this: Th...
  • Hematologist Robert Chen, M.D., is boosting scientific discovery at City of Hope and, by extension, across the nation. Just ask the National Cancer Institute. The institution recently awarded Chen the much-sought-after Clinical Investigator Team Leadership Award for boosting scientific discovery at City of Hope...
  • Great strides have been made in treating cancer – including lung cancer – but by the time people show symptoms of the disease, the cancer has usually advanced. That’s because, at early stages, lung cancer has no symptoms. Only recently has lung cancer screening become an option. (Read more about the risks...
  • Identifying cures for currently incurable diseases and providing patients with safe, fast and potentially lifesaving treatments is the focus of City of Hope’s new Alpha Clinic for Cell Therapy and Innovation (ACT-I). The clinic is funded by an $8 million, five-year grant from the California Institute for Regene...
  • Cancer is a couple’s disease. It affects not just the person diagnosed, but his or her partner as well. It also affects the ability of both people to communicate effectively. The Couples Coping with Cancer Together program at City of Hope teaches couples how to communicate and solve problems as a unit. He...
  • Chemotherapy drugs work by either killing cancer cells or by stopping them from multiplying, that is, dividing. Some of the more powerful drugs used to treat cancer do their job by interfering with the cancer cells’ DNA and RNA growth, preventing them from copying themselves and dividing. Such drugs, however, l...
  • During October, everything seems to turn pink – clothing, the NFL logo, tape dispensers, boxing gloves, blenders, soup cans, you name it – in order to raise awareness for what many believe is the most dangerous cancer that affects women: breast cancer. But, in addition to thinking pink, women should...
  • In February 2003, when she was only 16 months old, Maya Gallardo was diagnosed with acute myelogenous leukemia (AML) and, to make matters much worse, pneumonia. The pneumonia complicated what was already destined to be grueling treatment regimen. To assess the extent of her illness, Maya had to endure a spinal ...
  • Former smokers age 55 to 74 who rely on Medicare for health care services have just received a long-hoped-for announcement. Under a proposed decision from the Centers for Medicare and Medicaid Services, they’ll now have access to lung cancer screening with a low-dose CT scan. The proposed decision, announ...
  • City of Hope has a longstanding commitment to combating diabetes, a leading national and global health threat. Already, it’s scored some successes, from research that led to the development of synthetic human insulin – still used by millions of patients – to potentially lifesaving islet cell transplants. Diabet...
  • Dee Hunt never smoked. Neither did her five sisters and brothers. They didn’t have exposure to radon or asbestos, either. That didn’t prevent every one of them from being diagnosed with lung cancer. Their parents were smokers, but they’d all left home more than 30 years before any of them were diagn...
  • They may not talk about it, but women with cancers in the pelvic region, such as cervical cancer, bladder cancer and uterine cancer, often have problems controlling their urine, bowel or flatus. Although they may feel isolated, they’re far from alone. Many other women have such problems, too. In fact, nea...
  • Cancer that spreads to the liver poses a significant threat to patients, and a great challenge to surgeons. The organ’s anatomical complexity and its maze of blood vessels make removal of tumors difficult, even for specialized liver cancer surgeons. Following chemotherapy, the livers of cancer patients are not ...
  • A new study suggests that the colorectal cancer outlook is more grim than many thought, with the number of cases among young adults actually rising. But the study, which made headlines around the country, might not have the obvious message many consumers think. Donald David, M.D., chief of gastroenterology at C...
  • Patients faced with a cancer diagnosis have a lot to take in. It’s no surprise that many need help airing their concerns to their care teams. That’s why a City of Hope team developed SupportScreen, to enable patients to communicate their needs better. Last week, the tablet-based app hit an important milestone, ...